[Salicylic derivatives in the clinical treatment of inflammatory bowel disease: new perspectives].
Sulfasalazine is one of the most used drugs in the clinical management of inflammatory bowel disease. Nevertheless up to 30% of the patients experiment side effects related to the drug and end up having the drug diminished or withdrawn. The new salicylic-derivate compounds emerge as a reliable alternative for these patients. The authors review the new preparations and discuss their characteristics, indications and side effects.
Damião
A O
AO
Sipahi
A M
AM
D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D019804:Mesalamine; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use*
D000636:Aminosalicylic Acids; D012460:Sulfasalazine; D019804:Mesalamine
Derivados salicílicos no tratamento clínico da doença inflamatória intestinal: novas perspectivas.